Pharmaceutical/biotech - Articles - Page 8

China's Demand for $17,000 Gene-Altered Lab Mice Is Skyrocketing

April 4, 2019

President Xi Jinping’s drive to turn China into a biomedical powerhouse has pushed the country deeper into drug discovery and to the forefront of genetics.

The Trade War Didn't Stop a Google and Huawei AI Collaboration

April 3, 2019

Bloomberg

When Huawei announced its latest smartphone last week, the world’s largest telecommunications gear maker also shared another product. Track AI promises to pair software with Huawei devices to let “non-trained professionals” diagnose eye conditions.

The Brexit Day That Wasn't Leaves Britain Counting the Cost

April 1, 2019

Bloomberg

For more than two years, the clock ran down toward March 29, the day Prime Minister May pledged Britain would leave the European Union. As the drama rolls on, the costs mount from the Brexit day that wasn’t.

TechWatch

Emergency Response to Natural Disasters: Blockchain to the Rescue

March 20, 2019

Robert J. Bowman, SupplyChainBrain

Effective emergency response to a natural disaster requires rapid, coordinated action among multiple parties. Suffice to say that such a level of efficiency has been sadly lacking in many prior relief efforts. Can blockchain make it happen?

Enter Now for the 2019 Supply Chain Innovation Award Competition

March 7, 2019

SupplyChainBrain

The Council of Supply Chain Management Professionals (CSCMP) has extended the deadline to participate in its annual Supply Chain Innovation Award, in partnership with SupplyChainBrain.

Drug Price Fix Seen in Supply of Generics, Rebates, Senator Says

March 7, 2019

Bloomberg

Streamlining the pharmaceutical supply chain and getting more generic drugs to market would help consumers who can’t afford prescriptions, the head of the U.S. Senate’s special committee on aging says.

This Drug-Cost Nonprofit to Flip Pharma Supply Chain for Sourcing

This Drug Nonprofit Wants to Flip Pharma Supply Chain for Sourcing

February 21, 2019

Bloomberg

A nonprofit founded to address a pressing U.S. health-care problem by manufacturing much-needed drugs that have fallen into short supply, or that are too expensive, will start out with a different approach: buying the drugs from pharmaceutical companies.

PHARM Connect 2019: The Perfect Blend of Science and Business Development

February 19, 2019

Life science and business are going to meet at PHARM Connect on the 12-13 of March 2019 in Budapest, Hungary to continue the tradition of providing high calibre, customised professional partnering opportunities for pharma and biotech professionals from Central & Eastern European and beyond and deliver the crucial information they need to excel in their work. The influential annual gathering brings together over 400 global and regional decision-makers, top scientists, industry executives and business development leaders for the ninth time to identify new business opportunities, technologies, state-of-the-art formulation development strategies and to foster exchange of ideas on the role of the sector.

McKesson Sent Pharmacies Tampered Opioids, FDA Warns

February 13, 2019

Bloomberg

McKesson Corp., one of the largest U.S. drug distributors, sent pharmacies prescription opioids that had been removed from their bottles and replaced with over-the-counter painkillers, the Food and Drug Administration says.

When Hospitals Become Distributors, There Are More Ways to Save

February 6, 2019

Daniel Johnson, SCB Contributor

A growing number of healthcare systems are moving to self-distribution — where they order products directly from manufacturers and handle their own storage and order fulfillment.